Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia.

Mansouri L, Gunnarsson R, Sutton LA, Ameur A, Hooper SD, Mayrhofer M, Juliusson G, Isaksson A, Gyllensten U, Rosenquist R.

Am J Hematol. 2012 Jul;87(7):737-40. doi: 10.1002/ajh.23227. Epub 2012 Jun 3.

2.

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.

Sutton LA, Ljungström V, Mansouri L, Young E, Cortese D, Navrkalova V, Malcikova J, Muggen AF, Trbusek M, Panagiotidis P, Davi F, Belessi C, Langerak AW, Ghia P, Pospisilova S, Stamatopoulos K, Rosenquist R.

Haematologica. 2015 Mar;100(3):370-6. doi: 10.3324/haematol.2014.109777. Epub 2014 Dec 5.

3.

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.

Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM.

Blood. 2003 Jun 15;101(12):4944-51. Epub 2003 Feb 20.

4.

Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.

Liao W, Jordaan G, Nham P, Phan RT, Pelegrini M, Sharma S.

BMC Cancer. 2015 Oct 16;15:714. doi: 10.1186/s12885-015-1708-9.

5.

CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.

Buhl AM, Jurlander J, Geisler CH, Pedersen LB, Andersen MK, Josefsson P, Petersen JH, Leffers H.

Eur J Haematol. 2006 Jun;76(6):455-64. Epub 2006 Mar 9.

PMID:
16529606
6.

Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.

Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS.

Int J Mol Med. 2007 Oct;20(4):461-9.

PMID:
17786276
7.

Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion.

Aalto Y, El-Rifa W, Vilpo L, Ollila J, Nagy B, Vihinen M, Vilpo J, Knuutila S.

Leukemia. 2001 Nov;15(11):1721-8.

PMID:
11681413
8.

Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.

Mansouri M, Sevov M, Fahlgren E, Tobin G, Jondal M, Osorio L, Roos G, Olivecrona G, Rosenquist R.

Leuk Res. 2010 Mar;34(3):301-6. doi: 10.1016/j.leukres.2009.07.032. Epub 2009 Aug 25.

PMID:
19709746
9.

RNA-based markers as prognostic factors in chronic lymphocytic leukemia.

Sevov M, Rosenquist R, Mansouri L.

Expert Rev Hematol. 2012 Feb;5(1):69-79. doi: 10.1586/ehm.11.80. Review.

PMID:
22272707
10.
11.

Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.

Kim SZ, Chow KU, Kukoc-Zivojnov N, Boehrer S, Brieger A, Steimle-Grauer SA, Harder L, Hoelzer D, Mitrou PS, Weidmann E.

Leuk Lymphoma. 2004 Oct;45(10):2037-45.

PMID:
15370248
12.

The immunoglobulin genes and chronic lymphocytic leukemia (CLL).

Tobin G.

Ups J Med Sci. 2005;110(2):97-113. Review.

PMID:
16075892
13.

Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.

Nakagawa Y, Yamaguchi S, Hasegawa M, Nemoto T, Inoue M, Suzuki K, Hirokawa K, Kitagawa M.

Leuk Res. 2004 May;28(5):487-94.

PMID:
15068902
14.

Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.

Marantidou F, Dagklis A, Stalika E, Korkolopoulou P, Saetta A, Anagnostopoulos A, Laoutaris N, Stamatopoulos K, Belessi C, Scouras Z, Patsouris E.

Blood Cells Mol Dis. 2010 Apr 15;44(4):262-7. doi: 10.1016/j.bcmd.2009.12.005. Epub 2010 Feb 8. Erratum in: Blood Cells Mol Dis. 2010 Aug 15;45(2):180. Korkolopoulou, Panagiota [corrected to Korkolopoulou, Penelope].

PMID:
20117026
15.

A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.

Pekova S, Mazal O, Cmejla R, Hardekopf DW, Plachy R, Zejskova L, Haugvicova R, Jancuskova T, Karas M, Koza V, Smolej L, Bezdickova L, Kozak T.

Leuk Res. 2011 Jul;35(7):889-98. doi: 10.1016/j.leukres.2010.12.016. Epub 2011 Jan 13.

PMID:
21232794
16.

Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.

Chiaretti S, Tavolaro S, Marinelli M, Messina M, Del Giudice I, Mauro FR, Santangelo S, Piciocchi A, Peragine N, Truong S, Patten N, Ghia EM, Torrente I, De Propris MS, Nanni M, Lawrence J, Guarini A, Foà R.

Genes Chromosomes Cancer. 2011 Apr;50(4):263-74. doi: 10.1002/gcc.20852. Epub 2011 Jan 13.

PMID:
21319261
17.

Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.

Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.

Clin Cancer Res. 2010 Jan 15;16(2):620-8. doi: 10.1158/1078-0432.CCR-09-1638. Epub 2010 Jan 12.

18.

Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.

Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov SM, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R.

Blood. 2001 Apr 1;97(7):2098-104.

19.

Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.

Moshynska O, Sankaran K, Pahwa P, Saxena A.

J Natl Cancer Inst. 2004 May 5;96(9):673-82.

PMID:
15126604
20.

An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.

Alfarano A, Indraccolo S, Circosta P, Minuzzo S, Vallario A, Zamarchi R, Fregonese A, Calderazzo F, Faldella A, Aragno M, Camaschella C, Amadori A, Caligaris-Cappio F.

Blood. 1999 Apr 1;93(7):2327-35.

Supplemental Content

Support Center